Janssen Biotech gets CRL for Simponi sBLA
The company plans to call for an end-of review meeting with the FDA to comprehend the details of the CRL and to discuss regarding further steps to be
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Further, A*Star has chosen Agilent to offer automation technologies to biomedical researchers, enabling efficient drug screening in one location. A*STAR has now deployed Agilent’s dual BioCel 1200 integrated